W
WAVEMAN · COMPANY
CODA · Coda Octopus Group, Inc.
> Ask across nine datasets ⌘K
LIVE
TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475
← ALL COMPANIES

CODA

Coda Octopus Group, Inc.
MEDICAL DEVICES · SEARCH, DETECTION, NAVIGATION, GUIDANCE, AERONAUTICAL SYS · CIK 0001334325
SEC FILINGS☆ WATCH
INSIDER NET · 180D
-$1.3M
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
0
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
35
13F, latest reported quarter
REVENUE GROWTH
+30.7%
XBRL, annual
NET MARGIN
15.5%
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net -$1.3M over 180 days
-$1.2M of it by a 10%+ holder
below 62% of Medical Devices
CONGRESS
no member of Congress has reported trading it
FUNDS
35 funds added or opened last quarter
below 68% of Medical Devices
REVENUE
+30.7% year over year
more than 83% of Medical Devices
MARGIN
15.5% net margin
more than 88% of Medical Devices
BUYBACKS
no share repurchases reported
SHORT
1.9% of shares outstanding short · 2.6 days to cover · settled 2026-07-31
below 63% of Medical Devices
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
35 funds added or opened positions in the latest 13F quarter, of 64 holders.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN +26.7%
+26.7%12M
-3%+34%+72%+109%2025-092025-102025-122026-032026-052026-072026-09 2025-10-02 · Sondergaard Niels sold $1.2M2026-03-11 · Emerson John Steven sold $1.2M2025-09-19 · Sondergaard Niels sold $266.3K2025-09-22 · Sondergaard Niels sold $139.4K2025-09-23 · Sondergaard Niels sold $57.0K2026-03-11 · Emerson John Steven sold $43.4K2026-03-19 · Jardine Gayle Michelle sold $28.4K2026-03-11 · Emerson John Steven sold $14.4K
INSIDER SELL
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
The complete filing record, in one place.
The record shows a net $1.3M sold by insiders over 180 days, 35 funds added last quarter. Every figure is a federal filing, dated the day it became public.
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, Coda Octopus Group, Inc. insiders sold a net $1.3M of stock across 17 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-06.

INSIDER
FILED
SHARES
VALUE
Jardine Gayle Michelle
Interim CFO
SELL
2026-03-19
2,256.0
$28.4K
Emerson John Steven
SELL
2026-03-11
79,254.0
$1.2M
Emerson John Steven
SELL
2026-03-11
1,000.0
$14.4K
Emerson John Steven
SELL
2026-03-11
3,000.0
$43.4K
Sondergaard Niels
SELL
2025-10-02
150,000.0
$1.2M
17 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 12 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
ESSEX INVESTMENT MANAGEMENT CO LLC
322,278.0 sh
$3.1M
MARSHALL WACE, LLP
263,186.0 sh
$2.6M
Meros Investment Management, LP
254,310.0 sh
$2.5M
VANGUARD CAPITAL MANAGEMENT LLC
220,272.0 sh
$2.2M
Archon Capital Management LLC
140,000.0 sh
$1.4M
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
FORM 144
No planned-sale notices
No insider has notified an intent to sell. This is the panel to watch after a run-up.
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
1290 Essex Small Cap Growth Fund
$469.0K POSITION · AS OF 2026-04-30
0.4%
GRANDEUR PEAK GLOBAL MICROCAP FUND
$184.9K POSITION · AS OF 2026-04-30
0.4%
North Star Micro Cap Fund
$678.0K POSITION · AS OF 2026-02-28
0.4%
GRANDEUR PEAK GLOBAL REACH FUND
$305.8K POSITION · AS OF 2026-04-30
0.4%
Royce Quant Small-Cap Quality Value ETF
$30.3K POSITION · AS OF 2026-03-31
0.1%
Federated Hermes MDT Small Cap Growth Fund
$489.9K POSITION · AS OF 2026-04-30
0.1%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-102024-102023-102022-10
REVENUE$26.6M$20.3M$19.4M$22.2M
GROSS PROFIT$17.7M$14.2M$13.0M$15.2M
OPERATING INCOME$4.5M$3.6M$2.7M$5.0M
NET INCOME$4.1M$3.6M$3.1M$4.3M
EPS (DILUTED)0.370.320.280.38
OPERATING CASH FLOW$7.2M$2.5M$2.4M$6.7M
CASH$28.7M$22.5M$24.4M$22.9M
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-06 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-06 ALL SYSTEMS LIVE FOR MACHINES →